SARAH JUSTMANN: Open Payments
NPI 1407806128 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 22 payments from 10 companies in 2025. Trend: 2023 $576 · 2024 $665 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| ABBVIE INC. | 3 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| ACADIA Pharmaceuticals Inc | 2 | $33 |
| Alkermes, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: Qelbree, Sunosi, VRAYLAR, AUSTEDO XR, INGREZZA, NUPLAZID, ABILIFY ASIMTUFII, UZEDY.
Industry payments across IA — which companies pay providers there.
